These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6818716)

  • 1. Gossypol as oral contraceptive for male: trial case report.
    Hoshiai H; Uehara S; Mori R; Nagaike F; Tsuiki A; Suzuki M
    Tohoku J Exp Med; 1982 Nov; 138(3):275-80. PubMed ID: 6818716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between hormone profiles and the restoration of spermatogenesis in men treated with gossypol.
    Gu ZP; Wang YX; Sang GW; Wang WC; Chen ZX; Zhao XJ; Shao QX; Jiang Y
    Int J Androl; 1990 Aug; 13(4):253-7. PubMed ID: 2117586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of men in the recovery period immediately after the cessation of gossypol treatment.
    Meng GD; Zhu JC; Chen ZW; Wong LT; Zhang GY; Hu YZ; Ding JH; Wang XH; Qian SZ; Wang C
    Contraception; 1988 Feb; 37(2):119-28. PubMed ID: 3131064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined use of oral medroxyprogesterone acetate and methyltestosterone in a male contraceptive trial programme.
    Bain J; Rachlis V; Robert E; Khait Z
    Contraception; 1980 Apr; 21(4):365-79. PubMed ID: 6771093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC; Jouannet P; Marson J; Soumah A
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose gossypol for male contraception.
    Gu ZP; Mao BY; Wang YX; Zhang RA; Tan YZ; Chen ZX; Cao L; You GD; Segal SJ
    Asian J Androl; 2000 Dec; 2(4):283-7. PubMed ID: 11202417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men.
    Foegh M; Nicol K; Petersen IB; Schou G
    Contraception; 1980 Jun; 21(6):631-40. PubMed ID: 6775869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effect of gossypol on human sperm motility: relationship with time, temperature and concentration.
    Hong CY; Huang JJ; Wu P
    Hum Toxicol; 1989 Jan; 8(1):49-51. PubMed ID: 2714811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive. A multicenter, international, dose-finding study.
    Coutinho EM; Athayde C; Atta G; Gu ZP; Chen ZW; Sang GW; Emuveyan E; Adekunle AO; Mati J; Otubu J; Reidenberg MM; Segal SJ
    Contraception; 2000 Jan; 61(1):61-7. PubMed ID: 10745071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of norethandrolone and testosterone as a contraceptive agent for men.
    Brenner PF; Bernstein GS; Roy S; Jecht EW; Mishell DR
    Contraception; 1975 Feb; 11(2):193-207. PubMed ID: 1112088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ; Kletzky OA; Brenner PF; Mishell DR
    Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The search for male contraception. Men are different.
    Steinmann M
    RF Illus; 1982 Jun; ():29-31. PubMed ID: 12264477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with gossypol in non-Chinese men: a follow-up.
    Coutinho EM; Melo JF
    Contraception; 1988 Feb; 37(2):137-51. PubMed ID: 3286112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Looking for the "male pill".
    Herndon N
    Netw Res Triangle Park N C; 1992 Aug; 13(1):20-3. PubMed ID: 12317724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.